Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

KN-38-7271 to begin phase II trial in traumatic brain injury

Oct. 20, 2006

SB-15 advancing for anxiety associated with fragile X syndrome, autism

Oct. 20, 2006

Martek's DHA selected for NIH Alzheimer's study

Oct. 20, 2006

Combined data show superiority of aprepitant in postoperative nausea and vomiting

Oct. 20, 2006

Studies identify effective sedative doses of Aquavan

Oct. 20, 2006

Neuroprotective effects of the new JNK inhibitor ER-181304

Oct. 19, 2006

Abbott reports on a novel alpha7 nAChR agonist that provides cognitive enhancement

Oct. 19, 2006

SCH-747123 displays good BACE1 inhibiting profile in vitro and in vivo

Oct. 19, 2006

Ipsen present the broad therapeutic potential of BN-83026 in neurodegenerative diseases

Oct. 19, 2006

Arbor Vita and NoNO collaborate on novel treatment for stroke

Oct. 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026